Cardiogeni PLC (AQU:CGNI)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 7.00
0.00 (0.00%)
At close: Oct 30, 2026
Cardiogeni Revenue
In the fiscal year ending March 31, 2025, Cardiogeni had annual revenue of 7.79M GBP with 1,068.56% growth. That makes Cardiogeni the 37,185th largest company in the world by revenue and 723rd in the United Kingdom.
Revenue
7.79M
Revenue Growth
+1,068.56%
P/S Ratio
0.86
Revenue / Employee
2.60M
Employees
3
Market Cap
6.73M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 7.79M | 7.13M | 1,068.56% |
| Mar 31, 2024 | 667.03K | 10.00K | 1.52% |
| Mar 31, 2023 | 657.03K | -7.30K | -1.10% |
| Jul 31, 2020 | 664.32K | -118.58K | -15.15% |
| Jul 31, 2019 | 782.91K | 64.61K | 8.99% |
| Jul 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Capital For Colleagues | 3.18M |
| Time to Act | 2.28M |
| Inqo Investments | 1.58M |
| Valereum | 264.27K |
| Incanthera | 12.00K |